Ultrasound alone had a lower sensitivity of 45% for HCC detection than the combination with AFP determination at 63% (relative risk 0.88; 95% CI 0.83–0.93 for all stages, early-stage RR 0.81; 95% CI 0.71–0.93) [21]. This evidence concerns the gene AFP and hepatocellular carcinoma.